Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ATNM |
---|---|---|
09:32 ET | 1678 | 7.92 |
09:34 ET | 333 | 7.976 |
09:39 ET | 500 | 7.92 |
09:43 ET | 300 | 7.99 |
09:45 ET | 1582 | 8.03 |
09:48 ET | 100 | 8.08 |
09:50 ET | 100 | 8.09 |
09:52 ET | 911 | 8.01 |
09:54 ET | 13824 | 7.94 |
09:56 ET | 15400 | 8 |
09:57 ET | 4470 | 8.01 |
10:01 ET | 400 | 7.98 |
10:06 ET | 400 | 7.94 |
10:08 ET | 1000 | 7.98 |
10:10 ET | 649 | 7.9983 |
10:19 ET | 413 | 7.99 |
10:24 ET | 3500 | 7.98 |
10:26 ET | 2100 | 7.98 |
10:30 ET | 564 | 8.005 |
10:39 ET | 6773 | 7.9805 |
10:42 ET | 1100 | 7.93 |
10:50 ET | 100 | 7.965 |
10:57 ET | 120 | 7.9745 |
11:02 ET | 5300 | 7.97 |
11:06 ET | 100 | 7.98 |
11:08 ET | 5900 | 7.95 |
11:11 ET | 289 | 7.99 |
11:18 ET | 100 | 7.93 |
11:27 ET | 300 | 7.99 |
11:36 ET | 300 | 7.96 |
11:42 ET | 200 | 7.93 |
11:44 ET | 3637 | 7.92 |
11:45 ET | 3600 | 7.94 |
11:47 ET | 200 | 7.93 |
11:49 ET | 300 | 7.92 |
11:58 ET | 950 | 7.95 |
12:00 ET | 1261 | 7.888 |
12:05 ET | 716 | 7.87 |
12:07 ET | 200 | 7.87 |
12:14 ET | 100 | 7.8846 |
12:21 ET | 146 | 7.86 |
12:36 ET | 100 | 7.87 |
12:45 ET | 2133 | 7.86 |
12:48 ET | 18134 | 7.79 |
12:50 ET | 125 | 7.83 |
12:52 ET | 2100 | 7.81 |
12:54 ET | 100 | 7.79 |
12:57 ET | 380 | 7.79 |
12:59 ET | 800 | 7.82 |
01:01 ET | 100 | 7.8 |
01:03 ET | 108 | 7.8 |
01:06 ET | 500 | 7.82 |
01:10 ET | 580 | 7.84 |
01:12 ET | 100 | 7.83 |
01:21 ET | 2000 | 7.8323 |
01:24 ET | 171 | 7.83 |
01:26 ET | 1000 | 7.84 |
01:33 ET | 200 | 7.85 |
01:35 ET | 1100 | 7.86 |
01:42 ET | 300 | 7.875 |
01:44 ET | 3000 | 7.94 |
01:46 ET | 1068 | 7.91 |
01:51 ET | 100 | 7.9122 |
01:57 ET | 400 | 7.88 |
02:08 ET | 110 | 7.8587 |
02:11 ET | 100 | 7.88 |
02:13 ET | 250 | 7.855 |
02:15 ET | 398 | 7.8759 |
02:22 ET | 600 | 7.8534 |
02:24 ET | 300 | 7.86 |
02:26 ET | 100 | 7.88 |
02:33 ET | 100 | 7.865 |
02:36 ET | 1000 | 7.8718 |
02:40 ET | 1000 | 7.85 |
02:42 ET | 1000 | 7.8213 |
02:45 ET | 100 | 7.86 |
02:49 ET | 100 | 7.855 |
03:00 ET | 100 | 7.88 |
03:02 ET | 400 | 7.88 |
03:03 ET | 100 | 7.88 |
03:09 ET | 200 | 7.89 |
03:18 ET | 8540 | 7.86 |
03:21 ET | 222 | 7.865 |
03:27 ET | 100 | 7.88 |
03:32 ET | 100 | 7.89 |
03:38 ET | 700 | 7.84 |
03:39 ET | 200 | 7.85 |
03:41 ET | 1600 | 7.83 |
03:43 ET | 425 | 7.78 |
03:45 ET | 1400 | 7.78 |
03:48 ET | 1200 | 7.82 |
03:50 ET | 600 | 7.77 |
03:52 ET | 100 | 7.795 |
03:54 ET | 100 | 7.8 |
03:56 ET | 1716 | 7.82 |
03:57 ET | 332 | 7.8397 |
03:59 ET | 8678 | 7.82 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Actinium Pharmaceuticals Inc | 232.9M | -4.5x | --- |
Monte Rosa Therapeutics Inc | 233.0M | -1.5x | --- |
Fibrobiologics Inc | 232.6M | -6.9x | --- |
Ovid Therapeutics Inc | 233.4M | -4.6x | --- |
Omeros Corp | 235.3M | -1.4x | --- |
ATAI Life Sciences NV | 229.3M | -5.7x | --- |
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for people with relapsed and refractory acute myeloid leukemia. The Company focuses on advance Iomab-B for other blood cancers and next generation conditioning candidate Iomab-ACT to improve cell and gene therapy outcomes. The Company holds patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. Actinium-225 is a potent alpha-particle emitter that has high linear energy transfer capable of killing targeted cancer cells via double-strand breaks in DNA.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $232.9M |
---|---|
Revenue (TTM) | $81.0K |
Shares Outstanding | 29.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.21 |
EPS | $-1.72 |
Book Value | $1.32 |
P/E Ratio | -4.5x |
Price/Sales (TTM) | 2,875.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -61,645.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.